$1,650.00
We use our efficient, integration-free, small-molecule-based method to differentiate high-quality endothelial cells from human iPSCs. The differentiated endothelial cells recapitulate the phenotype and functional parameters of primary and in vivo endothelial cells.
We provide endothelial cells differentiated from an integration-free, control human iPSC line (ASE-9211), reprogrammed from the fibroblasts of an African American male donor. These high-purity (>90%) cells express high levels of endothelial cell biomarkers CD144 and CD31.
These iPSC-differentiated endothelial cells can be used as control lines to compare the phenotype and
functionality of patient-derived, genome-edited iPSC-derived endothelial cells for drug screening applications.
| Table Header | Table Header |
|---|---|
|
Age |
Neonate |
|
Gender |
Male |
|
Ethnicity |
African American |
|
Tissue source |
Dermal fibroblasts |
|
Reprogramming method |
Episomal |
|
Culture conditions |
Feeder-free |
Fill out the contact form below and a team member will be in touch within one business day.
